Total Holdings
149
Portfolio diversification across 149 positions
BMED
(NYSEARCA)iShares Health Innovation Active ETF
$30.69-- (--)
Loading... - Market loading
BMED ETF Holdings: iShares Health Innovation Active ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$10.02M
Total fund assets
Expense Ratio
0.55%
Annual management fee
Fund Issuer
BlackRock
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Johnson & Johnson | Stock | 3.82% |
| 2 |  | Medtronic plc | Stock | 3.33% |
| 3 |  | Gilead Sciences, Inc. | Stock | 3.31% |
| 4 | S SWX:ROG | Roche Holding AG | Stock | 3.16% |
| 5 |  | Abbott Laboratories | Stock | 3.11% |
| 6 |  | Exact Sciences Corporation | Stock | 3.02% |
| 7 |  | Biogen Inc | Stock | 2.79% |
| 8 | X XTSLA | BLK CSH FND TREASURY SL AGENCY | Stock | 2.68% |
| 9 |  | Guardant Health, Inc | Stock | 2.59% |
| 10 |  | Edwards Lifesciences Corporation | Stock | 2.59% |
| 11 | S SWX:NOVN | Novartis AG | Stock | 2.24% |
| 12 |  | Natera, Inc | Stock | 2.18% |
| 13 |  | Moderna, Inc. | Stock | 2.10% |
| 14 |  | Agilent Technologies, Inc | Stock | 2.05% |
| 15 |  | Insulet Corporation | Stock | 2.05% |
| 16 |  | Merck & Co., Inc | Stock | 1.99% |
| 17 | S SWX:LONN | Lonza Group AG | Stock | 1.98% |
| 18 | C CPH:GMAB | Genmab A/S | Stock | 1.95% |
| 19 |  | Amgen Inc. | Stock | 1.85% |
| 20 |  | IQVIA Holdings Inc. | Stock | 1.79% |
| 21 |  | Repligen Corporation | Stock | 1.77% |
| 22 |  | Illumina, Inc. | Stock | 1.73% |
| 23 |  | Danaher Corporation | Stock | 1.59% |
| 24 | E ETR:SRT3 | Sartorius Aktiengesellschaft | Stock | 1.59% |
| 25 | E EBR:UCB | UCB SA | Stock | 1.56% |
| 26 |  | AbbVie Inc | Stock | 1.52% |
| 27 |  | argenx NV ADR | Stock | 1.51% |
| 28 |  | Intuitive Surgical, Inc | Stock | 1.51% |
| 29 |  | Thermo Fisher Scientific Inc | Stock | 1.50% |
| 30 |  | Boston Scientific Corporation | Stock | 1.46% |
| 31 |  | Ionis Pharmaceuticals, Inc. | Stock | 1.38% |
| 32 |  | Neurocrine Biosciences, Inc | Stock | 1.35% |
| 33 |  | Rhythm Pharmaceuticals, Inc | Stock | 1.29% |
| 34 |  | DexCom, Inc | Stock | 1.24% |
| 35 |  | Charles River Laboratories International, Inc | Stock | 1.24% |
| 36 |  | Bio-Techne Corporation | Stock | 1.19% |
| 37 |  | Hologic, Inc | Stock | 1.13% |
| 38 |  | BridgeBio Pharma, Inc | Stock | 1.12% |
| 39 |  | West Pharmaceutical Services, Inc | Stock | 1.05% |
| 40 | T TSE:4523 | Eisai Co. Ltd. | Stock | 1.03% |
| 41 |  | Exelixis, Inc | Stock | 1.03% |
| 42 |  | AstraZeneca PLC | Stock | 0.98% |
| 43 |  | Bristol-Myers Squibb Company | Stock | 0.85% |
| 44 |  | QIAGEN N.V | Stock | 0.84% |
| 45 |  | Bio-Rad Laboratories, Inc | Stock | 0.82% |
| 46 |  | Axsome Therapeutics, Inc | Stock | 0.68% |
| 47 | S SWX:GALD | Galderma Group N | Stock | 0.66% |
| 48 |  | Protagonist Therapeutics Inc | Stock | 0.66% |
| 49 |  | Teva Pharmaceutical Industries Limited | Stock | 0.65% |
| 50 |  | Tempus AI, Inc. Class A Common Stock | Stock | 0.64% |